|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2009-03-10- -2009-03-11 Purchase |
2009-03-20 4:43 pm | PEPLIN INC | PLIN | KERINS PATRICK J (10% owner) | 15,219 | $0.49 | $7,457 | 1,301,782 (Indirect) | View |
| Transaction & Date |
Reported Date |
Company | Symbol | Insider Relationship | Shares Traded | Average Price |
Total Amount |
Shares Ownership |
Filing |
| 2009-11-11 Equity Swap |
2009-11-13 11:48 am | PEPLIN INC | PLIN | KERINS PATRICK J (10% owner) | 1,301,782 | $16.99 | $22,117,269 | 0 (Indirect) |
View |
| Transaction & Date |
Reported Date | Exercisable Expiration | Company | Symbol | Insider Relationship |
Shares Traded |
Conversion Price | Shares Ownership |
Filing |
| 2009-11-11 Equity Swap |
2009-11-13 11:48 am | 2008-10-23 2013-10-23 |
PEPLIN INC | PLIN | KERINS PATRICK J (10% owner) | 264,608 | $7.86 | 0 (Indirect) | View |
| 2009-10-30 Purchase | 2009-11-03 4:52 pm |
2009-10-30 2016-10-30 | SUNESIS PHARMACEUTICALS INC | SNSS | KERINS PATRICK J (10% owner) | 3,331,660 | $0.22 | 3,331,660 (Indirect) | View |
| 2009-10-30 Purchase | 2009-11-03 4:52 pm | N/A N/A | SUNESIS PHARMACEUTICALS INC | SNSS | KERINS PATRICK J (10% owner) | 333,166 | $0 | 999,499 (Indirect) | View |
|
© 2005-2009 SecForm4.Com All rights reserved. Archives: 2009 2008 2007 2006 2005 2004 ... Sat, 21 Nov 2009 18:31:00 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |